A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Blueprint Medicines Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Pfizer
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Johns Hopkins University
NextCure, Inc.
ADC Therapeutics S.A.
University of Florida
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Zai Lab (Hong Kong), Ltd.
ExcellaBio LLC
Incyte Corporation
Seagen Inc.
KitovPharma
AIDS Malignancy Consortium
UMC Utrecht
CureOne
University Hospital Tuebingen
Universitätsmedizin Mannheim
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Cancer Research UK